Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | NLRP3 | Q96P20 | 3/20 | 0.48 |
| ▸ | PPID | Q08752 | 1/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28250551 | 0.89 | ALDH1A1 (0.46) | ALDH1A1HTTKDM4ETHRBTDP1 | |
| SCHEMBL27861807 | 0.86 | ALDH1A1 (0.47) | ALDH1A1HTTKDM4ETHRBTDP1 | |
| SCHEMBL2496609 | 0.86 | ALDH1A1 (0.60) | ALDH1A1HTTTHRBTDP1LMNA | |
| SCHEMBL5786263 | 0.85 | GAA (0.54) | ALDH1A1HTTKDM4ETHRBTDP1 | |
| Hydrochloric Acid SCHEMBL7406915 | 0.85 | ALDH1A1 (0.58) | ALDH1A1HTTTHRBTDP1LMNA | |
| SCHEMBL11435584 | 0.84 | ALDH1A1 (0.49) | ALDH1A1HTTTHRBTDP1LMNA | |
| SCHEMBL29926725 | 0.83 | ALDH1A1 (0.49) | ALDH1A1HTTKDM4ETHRBTDP1 | |
| SCHEMBL6909147 | 0.83 | ALDH1A1 (0.49) | ALDH1A1HTTKDM4ETHRBTDP1 | |
| Hydrochloric Acid SCHEMBL8122459 | 0.83 | GAA (0.53) | ALDH1A1HTTKDM4ETHRBTDP1 | |
| SCHEMBL7429554 | 0.83 | L3MBTL1 (0.46) | ALDH1A1HTTKDM4ETHRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6294549-B1 | COMPOUNDS USEFUL FOR INHIBITING RESTENOSIS, ANGIOGENESIS, ATHEROSCLEROSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, INFLAMMATION OR TUMOR GROWTH. | MERCK & CO., INC. | 2001-09-25 | — | — | US | disclosed |
| US-5952306-A | INHIBITING THE BINDING OF FIBRINOGEN TO BLOOD PLATELETS AND INHIBITING THE AGGREGATION OF BLOOD PLATELETS; INHIBITING OSTEOCLAST CELLULAR ADHESION TO BONE SURFACES | MERCK & CO., INC. (US) | 1999-09-14 | — | — | US | disclosed |
| EP-0880511-A4 | INTEGRIN RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 1999-06-16 | — | — | EP | disclosed |
| EP-0880511-A1 | INTEGRIN RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997026250-A1 | INTEGRIN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1997-07-24 | — | — | WO | disclosed |